venBio Partners
Latest statistics and disclosures from venBio Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PHVS, ALMS, HRMY, Artiva Biotherapeutics, SLRN, and represent 90.92% of venBio Partners's stock portfolio.
- Added to shares of these 1 stock: Artiva Biotherapeutics (+$24M).
- Started 1 new stock position in Artiva Biotherapeutics.
- Reduced shares in these 2 stocks: HRMY (-$17M), ELEV (-$6.6M).
- Sold out of its position in ELEV.
- venBio Partners was a net buyer of stock by $79k.
- venBio Partners has $194M in assets under management (AUM), dropping by -16.06%.
- Central Index Key (CIK): 0001776382
Tip: Access up to 7 years of quarterly data
Positions held by venBio Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for venBio Partners
venBio Partners holds 6 positions in its portfolio as reported in the September 2024 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Pharvaris N V (PHVS) | 40.9 | $79M | 4.3M | 18.52 |
|
|
Alumis (ALMS) | 15.5 | $30M | 2.8M | 10.68 |
|
|
Harmony Biosciences Hldgs In (HRMY) | 12.7 | $25M | -40% | 615k | 40.00 |
|
Artiva Biotherapeutics | 12.1 | $24M | NEW | 1.5M | 15.45 |
|
Acelyrin (SLRN) | 9.8 | $19M | 3.9M | 4.93 |
|
|
Alx Oncology Hldgs (ALXO) | 9.1 | $18M | 9.7M | 1.82 |
|
Past Filings by venBio Partners
SEC 13F filings are viewable for venBio Partners going back to 2019
- venBio Partners 2024 Q3 filed Nov. 14, 2024
- venBio Partners 2024 Q2 filed Aug. 14, 2024
- venBio Partners 2024 Q1 filed May 15, 2024
- venBio Partners 2023 Q4 filed Feb. 14, 2024
- venBio Partners 2023 Q3 filed Nov. 14, 2023
- venBio Partners 2023 Q2 filed Aug. 14, 2023
- venBio Partners 2023 Q1 filed May 15, 2023
- venBio Partners 2022 Q4 filed Feb. 14, 2023
- venBio Partners 2022 Q3 filed Nov. 14, 2022
- venBio Partners 2022 Q2 filed Aug. 15, 2022
- venBio Partners 2022 Q1 filed May 16, 2022
- venBio Partners 2021 Q4 filed Feb. 14, 2022
- venBio Partners 2021 Q3 filed Nov. 15, 2021
- venBio Partners 2021 Q2 filed Aug. 16, 2021
- venBio Partners 2021 Q1 filed May 17, 2021
- venBio Partners 2020 Q4 filed Feb. 16, 2021